https://www.selleckchem.com/products/r428.html
renal markers, as well as individualized fluid management, can play a key role in AKI prevention. Hypovolemia and dehydration are a frequent cause of AKI among COVID-19 patients. Those who develop AKI during hospitalization display worse prognostic factors in terms of pulmonary damage, renal damage, and analytical findings. We believe that monitorization of renal markers, as well as individualized fluid management, can play a key role in AKI prevention. Community Acquired Pneumonia (CAP) is common disease that can be treated in Hospital At
Like
Comment
Share
